Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.

Weinmann HJ, Brasch RC, Press WR, Wesbey GE.

AJR Am J Roentgenol. 1984 Mar;142(3):619-24.

PMID:
6607655
3.

[A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].

Patrizio G, Pavone P, Cardone G, Pietroletti R, Passariello R, Tettamanti E, Musu C, Felder E.

Radiol Med. 1990 May;79(5):458-62. Italian.

PMID:
2359853
4.

Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex.

Brasch RC, Weinmann HJ, Wesbey GE.

AJR Am J Roentgenol. 1984 Mar;142(3):625-30.

PMID:
6607656
5.

Aerosolized gadolinium-DTPA enhances the magnetic resonance signal of extravascular lung water.

Montgomery AB, Paajanen H, Brasch RC, Murray JF.

Invest Radiol. 1987 May;22(5):377-81.

PMID:
3597005
6.

Biodistribution of GdCl3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues.

Barnhart JL, Kuhnert N, Bakan DA, Berk RN.

Magn Reson Imaging. 1987;5(3):221-31.

PMID:
3626790
7.

The functional effects of gadolinium-DTPA on the isolated perfused rat kidney.

Brown PW, Haylor JL, Morcos SK, el Nahas AM.

Eur J Radiol. 1993 Feb;16(2):85-9.

PMID:
8462585
8.

Gadolinium-DTPA: a new contrast agent for magnetic resonance imaging.

Niendorf HP, Felix R, Laniado M, Schörner W, Claussen C, Weinmann HJ.

Radiat Med. 1985 Jan-Mar;3(1):7-12.

PMID:
4070676
9.

Use of gadolinium-DTPA as a myocardial perfusion agent: potential applications and limitations for magnetic resonance imaging.

Johnston DL, Liu P, Lauffer RB, Newell JB, Wedeen VJ, Rosen BR, Brady TJ, Okada RD.

J Nucl Med. 1987 May;28(5):871-7.

11.

Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.

Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H.

Invest Radiol. 1993 Mar;28 Suppl 1:S28-43. Review.

PMID:
8486501
12.

Delayed magnetic resonance hepatic imaging with gadolinium-DTPA.

Nelson RC, Umpierrez ME, Chezmar JL, Bernardino ME.

Invest Radiol. 1988 Jul;23(7):509-11.

PMID:
3170138
13.

Magnetic resonance imaging of local soft tissue inflammation using gadolinium-DTPA.

Paajanen H, Brasch RC, Schmiedl U, Ogan M.

Acta Radiol. 1987 Jan-Feb;28(1):79-83.

PMID:
2952148
14.

Whole-body autoradiographic studies in rats with gadolinium-diethylenetriaminepentaacetic acid, a new contrast agent for magnetic resonance imaging.

Täuber U, Weinmann HJ, Panzer M, Acksteiner B, Vollert B, Schulze PE.

Arzneimittelforschung. 1986 Jul;36(7):1089-91.

PMID:
3768078
15.
16.

Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats.

Schmiedl U, Ogan MD, Moseley ME, Brasch RC.

AJR Am J Roentgenol. 1986 Dec;147(6):1263-70.

PMID:
3535459
17.

Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.

Cohan RH, Leder RA, Herzberg AJ, Hedlund LW, Wheeler CT, Beam CA, Nadel SN, Dunnick NR.

Invest Radiol. 1991 Mar;26(3):224-6.

PMID:
2055727
18.

Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.

Pettersson H, Ackerman N, Kaude J, Googe RE, Mancuso AA, Scott KN, Hackett RH, Hager DA, Caballero S.

Acta Radiol. 1987 Jan-Feb;28(1):75-8.

PMID:
2952147
19.

First use of GdDTPA/dimeglumine in man.

Laniado M, Weinmann HJ, Schörner W, Felix R, Speck U.

Physiol Chem Phys Med NMR. 1984;16(2):157-65.

PMID:
6505042
20.

Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.

Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC.

Invest Radiol. 1987 Aug;22(8):665-71. Erratum in: Invest Radiol 1988 Dec;23(12):961.

PMID:
3667174

Supplemental Content

Support Center